FIBRINOGEN RECEPTOR ANTAGONISTS AND THEIR USE
This invention relates to novel fused bicyclic compounds of the general formula (I): wherein the symbols are defined herein, to pharmaceutical compositions containing the compounds, processes for preparing the compounds, and to methods of using the compounds, alone or in combination with other thera...
Gespeichert in:
Hauptverfasser: | , , , , , , , , |
---|---|
Format: | Patent |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext bestellen |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | |
---|---|
container_issue | |
container_start_page | |
container_title | |
container_volume | |
creator | PINTO DE SOUZA ELEANOR KULKARNI-ALMEIDA ASHA GANGOPADHYAY ASHOK KUMAR PANICKER RADHA BHASKAR KRISHNAN SRIDEVI GUPTE RAVINDRA DATTATRAYA LAL BANSI RAO VADLAMUDI V.S.V GOLE GOPAL VISHNU |
description | This invention relates to novel fused bicyclic compounds of the general formula (I): wherein the symbols are defined herein, to pharmaceutical compositions containing the compounds, processes for preparing the compounds, and to methods of using the compounds, alone or in combination with other therapeutic agents. The compounds are antagonists of the platelet glycoprotein IIb/IIIa fibrinogen receptor complex, and are therefore useful for the inhibition of platelet aggregation, and for the treatment of thrombotic diseases and other diseases. |
format | Patent |
fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_US2010256161A1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>US2010256161A1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_US2010256161A13</originalsourceid><addsrcrecordid>eNrjZNB183QK8vTzd3f1UwhydXYNCPEPUnD0C3F09_fzDA4JBrJdFEI8XD2DFEKDXXkYWNMSc4pTeaE0N4Oym2uIs4duakF-fGpxQWJyal5qSXxosJGBoYGRqZmhmaGjoTFxqgBb_SZm</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>FIBRINOGEN RECEPTOR ANTAGONISTS AND THEIR USE</title><source>esp@cenet</source><creator>PINTO DE SOUZA ELEANOR ; KULKARNI-ALMEIDA ASHA ; GANGOPADHYAY ASHOK KUMAR ; PANICKER RADHA BHASKAR ; KRISHNAN SRIDEVI ; GUPTE RAVINDRA DATTATRAYA ; LAL BANSI ; RAO VADLAMUDI V.S.V ; GOLE GOPAL VISHNU</creator><creatorcontrib>PINTO DE SOUZA ELEANOR ; KULKARNI-ALMEIDA ASHA ; GANGOPADHYAY ASHOK KUMAR ; PANICKER RADHA BHASKAR ; KRISHNAN SRIDEVI ; GUPTE RAVINDRA DATTATRAYA ; LAL BANSI ; RAO VADLAMUDI V.S.V ; GOLE GOPAL VISHNU</creatorcontrib><description>This invention relates to novel fused bicyclic compounds of the general formula (I): wherein the symbols are defined herein, to pharmaceutical compositions containing the compounds, processes for preparing the compounds, and to methods of using the compounds, alone or in combination with other therapeutic agents. The compounds are antagonists of the platelet glycoprotein IIb/IIIa fibrinogen receptor complex, and are therefore useful for the inhibition of platelet aggregation, and for the treatment of thrombotic diseases and other diseases.</description><language>eng</language><subject>CHEMISTRY ; HETEROCYCLIC COMPOUNDS ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2010</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20101007&DB=EPODOC&CC=US&NR=2010256161A1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25564,76547</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20101007&DB=EPODOC&CC=US&NR=2010256161A1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>PINTO DE SOUZA ELEANOR</creatorcontrib><creatorcontrib>KULKARNI-ALMEIDA ASHA</creatorcontrib><creatorcontrib>GANGOPADHYAY ASHOK KUMAR</creatorcontrib><creatorcontrib>PANICKER RADHA BHASKAR</creatorcontrib><creatorcontrib>KRISHNAN SRIDEVI</creatorcontrib><creatorcontrib>GUPTE RAVINDRA DATTATRAYA</creatorcontrib><creatorcontrib>LAL BANSI</creatorcontrib><creatorcontrib>RAO VADLAMUDI V.S.V</creatorcontrib><creatorcontrib>GOLE GOPAL VISHNU</creatorcontrib><title>FIBRINOGEN RECEPTOR ANTAGONISTS AND THEIR USE</title><description>This invention relates to novel fused bicyclic compounds of the general formula (I): wherein the symbols are defined herein, to pharmaceutical compositions containing the compounds, processes for preparing the compounds, and to methods of using the compounds, alone or in combination with other therapeutic agents. The compounds are antagonists of the platelet glycoprotein IIb/IIIa fibrinogen receptor complex, and are therefore useful for the inhibition of platelet aggregation, and for the treatment of thrombotic diseases and other diseases.</description><subject>CHEMISTRY</subject><subject>HETEROCYCLIC COMPOUNDS</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2010</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZNB183QK8vTzd3f1UwhydXYNCPEPUnD0C3F09_fzDA4JBrJdFEI8XD2DFEKDXXkYWNMSc4pTeaE0N4Oym2uIs4duakF-fGpxQWJyal5qSXxosJGBoYGRqZmhmaGjoTFxqgBb_SZm</recordid><startdate>20101007</startdate><enddate>20101007</enddate><creator>PINTO DE SOUZA ELEANOR</creator><creator>KULKARNI-ALMEIDA ASHA</creator><creator>GANGOPADHYAY ASHOK KUMAR</creator><creator>PANICKER RADHA BHASKAR</creator><creator>KRISHNAN SRIDEVI</creator><creator>GUPTE RAVINDRA DATTATRAYA</creator><creator>LAL BANSI</creator><creator>RAO VADLAMUDI V.S.V</creator><creator>GOLE GOPAL VISHNU</creator><scope>EVB</scope></search><sort><creationdate>20101007</creationdate><title>FIBRINOGEN RECEPTOR ANTAGONISTS AND THEIR USE</title><author>PINTO DE SOUZA ELEANOR ; KULKARNI-ALMEIDA ASHA ; GANGOPADHYAY ASHOK KUMAR ; PANICKER RADHA BHASKAR ; KRISHNAN SRIDEVI ; GUPTE RAVINDRA DATTATRAYA ; LAL BANSI ; RAO VADLAMUDI V.S.V ; GOLE GOPAL VISHNU</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_US2010256161A13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>2010</creationdate><topic>CHEMISTRY</topic><topic>HETEROCYCLIC COMPOUNDS</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>PINTO DE SOUZA ELEANOR</creatorcontrib><creatorcontrib>KULKARNI-ALMEIDA ASHA</creatorcontrib><creatorcontrib>GANGOPADHYAY ASHOK KUMAR</creatorcontrib><creatorcontrib>PANICKER RADHA BHASKAR</creatorcontrib><creatorcontrib>KRISHNAN SRIDEVI</creatorcontrib><creatorcontrib>GUPTE RAVINDRA DATTATRAYA</creatorcontrib><creatorcontrib>LAL BANSI</creatorcontrib><creatorcontrib>RAO VADLAMUDI V.S.V</creatorcontrib><creatorcontrib>GOLE GOPAL VISHNU</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>PINTO DE SOUZA ELEANOR</au><au>KULKARNI-ALMEIDA ASHA</au><au>GANGOPADHYAY ASHOK KUMAR</au><au>PANICKER RADHA BHASKAR</au><au>KRISHNAN SRIDEVI</au><au>GUPTE RAVINDRA DATTATRAYA</au><au>LAL BANSI</au><au>RAO VADLAMUDI V.S.V</au><au>GOLE GOPAL VISHNU</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>FIBRINOGEN RECEPTOR ANTAGONISTS AND THEIR USE</title><date>2010-10-07</date><risdate>2010</risdate><abstract>This invention relates to novel fused bicyclic compounds of the general formula (I): wherein the symbols are defined herein, to pharmaceutical compositions containing the compounds, processes for preparing the compounds, and to methods of using the compounds, alone or in combination with other therapeutic agents. The compounds are antagonists of the platelet glycoprotein IIb/IIIa fibrinogen receptor complex, and are therefore useful for the inhibition of platelet aggregation, and for the treatment of thrombotic diseases and other diseases.</abstract><oa>free_for_read</oa></addata></record> |
fulltext | fulltext_linktorsrc |
identifier | |
ispartof | |
issn | |
language | eng |
recordid | cdi_epo_espacenet_US2010256161A1 |
source | esp@cenet |
subjects | CHEMISTRY HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
title | FIBRINOGEN RECEPTOR ANTAGONISTS AND THEIR USE |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-26T23%3A25%3A53IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=PINTO%20DE%20SOUZA%20ELEANOR&rft.date=2010-10-07&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EUS2010256161A1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |